These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 9765404
1. Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes. Pepperl S, Benninger-Döring G, Modrow S, Wolf H, Jilg W. J Virol; 1998 Nov; 72(11):8644-9. PubMed ID: 9765404 [Abstract] [Full Text] [Related]
2. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. Bogedain C, Wolf H, Modrow S, Stuber G, Jilg W. J Virol; 1995 Aug; 69(8):4872-9. PubMed ID: 7609055 [Abstract] [Full Text] [Related]
4. Tetramer-assisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein-Barr virus-specific CD8+ T cells. Kuzushima K, Hayashi N, Kudoh A, Akatsuka Y, Tsujimura K, Morishima Y, Tsurumi T. Blood; 2003 Feb 15; 101(4):1460-8. PubMed ID: 12393434 [Abstract] [Full Text] [Related]
5. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. Gavioli R, Kurilla MG, de Campos-Lima PO, Wallace LE, Dolcetti R, Murray RJ, Rickinson AB, Masucci MG. J Virol; 1993 Mar 15; 67(3):1572-8. PubMed ID: 7679748 [Abstract] [Full Text] [Related]
6. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. de Campos-Lima PO, Levitsky V, Brooks J, Lee SP, Hu LF, Rickinson AB, Masucci MG. J Exp Med; 1994 Apr 01; 179(4):1297-305. PubMed ID: 7511684 [Abstract] [Full Text] [Related]
7. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. Steven NM, Annels NE, Kumar A, Leese AM, Kurilla MG, Rickinson AB. J Exp Med; 1997 May 05; 185(9):1605-17. PubMed ID: 9151898 [Abstract] [Full Text] [Related]
8. Identification of CD8+ T-cell epitopes specific for immediate-early transactivator Rta of Epstein-Barr virus. Yu H, Srinivasan N, Ren E, Chan S. Hum Immunol; 2005 May 05; 66(5):483-93. PubMed ID: 15935885 [Abstract] [Full Text] [Related]
9. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. Lee SP, Thomas WA, Murray RJ, Khanim F, Kaur S, Young LS, Rowe M, Kurilla M, Rickinson AB. J Virol; 1993 Dec 05; 67(12):7428-35. PubMed ID: 7693972 [Abstract] [Full Text] [Related]
10. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection. Silins SL, Cross SM, Elliott SL, Pye SJ, Burrows JM, Moss DJ, Misko IS. Int Immunol; 1997 Nov 05; 9(11):1745-55. PubMed ID: 9418135 [Abstract] [Full Text] [Related]
11. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ. J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044 [Abstract] [Full Text] [Related]
12. Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cells. Murray RJ, Brooks JM, Rickinson AB, Rowe M. Eur J Immunol; 1990 Mar 01; 20(3):659-64. PubMed ID: 1690661 [Abstract] [Full Text] [Related]
13. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. Murray RJ, Wang D, Young LS, Wang F, Rowe M, Kieff E, Rickinson AB. J Virol; 1988 Oct 01; 62(10):3747-55. PubMed ID: 2843672 [Abstract] [Full Text] [Related]
14. Crystal structure of suboptimal viral fragments of Epstein Barr Virus Rta peptide-HLA complex that stimulate CD8 T cell response. Huan X, Zhuo Z, Xiao Z, Ren EC. Sci Rep; 2019 Nov 13; 9(1):16660. PubMed ID: 31723204 [Abstract] [Full Text] [Related]
15. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers. Benninger-Döring G, Pepperl S, Deml L, Modrow S, Wolf H, Jilg W. Virology; 1999 Nov 25; 264(2):289-97. PubMed ID: 10562493 [Abstract] [Full Text] [Related]
16. HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences. Midgley RS, Bell AI, Yao QY, Croom-Carter D, Hislop AD, Whitney BM, Chan AT, Johnson PJ, Rickinson AB. J Virol; 2003 Nov 25; 77(21):11507-16. PubMed ID: 14557636 [Abstract] [Full Text] [Related]
17. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ. J Exp Med; 1992 Jul 01; 176(1):169-76. PubMed ID: 1377222 [Abstract] [Full Text] [Related]
18. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. Brooks JM, Murray RJ, Thomas WA, Kurilla MG, Rickinson AB. J Exp Med; 1993 Sep 01; 178(3):879-87. PubMed ID: 7688791 [Abstract] [Full Text] [Related]
19. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1. Stuber G, Dillner J, Modrow S, Wolf H, Székely L, Klein G, Klein E. Int Immunol; 1995 Apr 01; 7(4):653-63. PubMed ID: 7547693 [Abstract] [Full Text] [Related]
20. Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides. Reali E, Guerrini R, Giori B, Borghi M, Marastoni M, Tomatis R, Traniello S, Masucci MG, Gavioli R. Clin Exp Immunol; 1996 Aug 01; 105(2):369-75. PubMed ID: 8706347 [Abstract] [Full Text] [Related] Page: [Next] [New Search]